INTRODUCTION
Iron is an essential element for the growth and maintenance of cells in all organisms. It participates in numerous critical biochemical processes, such as electron transfer for ATP synthesis in mitochondria, activation of ribonucleotide reductase (RR) for DNA synthesis, oxygen transfer by haemoglobin and activities of many other metalloenzymes [1] [2] [3] [4] . In contrast with its essential role for cellular maintenance, an excess accumulation of iron can also raise serious health risks. Liver is a principal target organ for iron toxicity, because it functions to take up and store all the excess iron in the body. Heavy iron load has often been found in several liver diseases, including cirrhosis and hepatocellular carcinoma [5] [6] [7] [8] [9] [10] . Therefore it has been suggested that the hepatic iron content, which results from its regulated uptake and availability, is closely associated with cellular proliferation and disorders in liver, regardless of their causes [11] .
The proliferation ability of a cell is represented by a concerted modulation of cell-cycle progression. Transition from G " to Sphase basically progresses by catalytically active complexes composed of several different cyclins and cyclin-dependent kinases (CDKs), and is tightly controlled by CDK inhibitors (CDKIs). In mammalian cells, two families of CDKIs have been described on the basis of protein sequence similarity : the Cip\Kip (CDK-interacting protein\kinase-inhibitory protein) family, including p21 Cip" and p27 Kip" , and the INK (inhibitors of CDK4) family, including p16 INK%A and p15 INK%B [12, 13] . Manipulation of cell-cycle progression by these CDKIs is a critical step in Abbreviations used : BrdU, 5-bromo-2h-deoxyuridine ; CDK, cyclin-dependent kinases ; CDKI, cyclin-dependent kinase inhibitors ; Cip/Kip, CDKinteracting protein/kinase-inhibitory protein ; DAPI, 4,6-diamidino-2-phenylindole ; DFO, desferroxamine mesylate ; DMEM, Dulbecco's modified Eagle's medium ; FBS, fetal bovine serum ; GAPDH, glyceraldehyde-3-phosphate dehydrogenase ; INK, inhibitors of CDK4 ; PI, propidium iodide ; PARP, poly(ADP-ribose) polymerase ; RR, ribonucleotide reductase ; RT, reverse transcriptase ; SA-β-gal, senescence-associated β-galactosidase ; TGF-β1, transforming growth factor β1. 1 To whom correspondence should be addressed (e-mail ypeace!madang.ajou.ac.kr).
the G " arrest. Furthermore, the induction of p27 Kip" was accompanied by an increased level of transforming growth factor β1 (TGF-β1) mRNA. When neutralized with an anti-(TGF-β1) antibody, p27 Kip" induction was completely abolished, indicating that TGF-β1 is the major inducer of p27 Kip" . Finally, DFOinduced senescence-like arrest was found to be independent of p53, since cell-cycle arrest was still observed with two p53-negative cell lines, Huh7 and Hep3B cells. In conclusion, DFO induced senescence-like G " arrest in hepatocyte cell lines and this was associated with the induction of p27 Kip" through TGF-β1, but was independent of p53.
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determining the fate of cells to apoptosis, differentiation or senescence. ' Replicative senescence ' is characterized by an irreversible state of cell-cycle arrest and is believed to play an important role in safeguarding against tumour formation by suppressing the emergence or growth of immortal cells [14, 15] . Overexpression or induction of p53, p16 INK%A or p21 Cip" has been widely shown to cause premature senescence through G " arrest, indicating that these CDKIs and p53 are important mediators [16] [17] [18] . In contrast with the above, however, the involvement of p27 Kip" and p15 INK%B in cellular senescence is not well understood yet. A recent report [19] has described that senescence-like cellcycle arrest by a phosphoinositide 3-kinase inhibitor was mediated through the accumulation of p27 Kip" , whereas p16 INK%A , p21 Cip" , p19 ARF (where ARF is alternative reading frame) and p53 were down-regulated. Activation of p15 INK%B has been observed only in senescent lymphocytes and was accompanied with an increase in p16 INK%A [20] .
Cells deprived of iron do not proceed from G " to S-phase of the cell cycle and, therefore, iron chelation has often been employed to inhibit the growth of cancer cells. Indeed, desferroxamine mesylate (DFO), a commonly used soluble iron chelator, has been shown to have anti-proliferative effects on a number of cell lines in itro, including hepatoma, leukaemia and neuroblastoma cells [21] [22] [23] [24] . Moreover, in several in i o trials using nude mice and rats, DFO was found to decrease the incidence of cancer development [25, 26] . Despite various studies on growth inhibitory effects of DFO, its detailed molecular mechanism is poorly understood. Recently, we found that treatment of Chang cells, an immortalized human hepatocyte cell line, with subcytotoxic concentrations of DFO induced enlarged and flattened cellular morphology (G. Yoon, H.-J. Kim, Y.-S. Yoon, H. Cho and J.-H. Lee, unpublished work), which is one of the typical characteristics of cellular senescence. This phenotype appeared within 3 days and lasted up to 10 days, and was irreversible. In the present study, we have explored the mechanism involved in the senescence-like growth arrest of hepatocyte cell lines induced by DFO. We conclude that DFO induced senescence-like G " arrest in hepatocyte cell lines and the arrest was associated with p27 Kip" induction through transforming growth factor β1 (TGF-β1) expression, but was independent of p53.
MATERIALS AND METHODS

Cell culture and growth curves
Chang cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing F-12 nutrient mixture (1 :1, v\v ; DMEM\ F12 ; Gibco BRL, Gaithersburg, MD, U.S.A.) and 10 % (v\v) fetal bovine serum (FBS ; Gibco BRL) in a 37 mC incubator with 5 % CO # in air. Hep3B and Huh7 cells were cultured in DMEM (Gibco BRL) containing 10 % FBS. Growth rates of DFOtreated Chang cells were monitored by counting the viable cells. Briefly, 1i10$ cells were seeded into 24-well plates, cultured in DMEM\F12 containing 10 % (v\v) FBS for 12 h, and treated with various concentrations of DFO for the indicated periods. The cells were kept in culture by refreshing with DMEM\F12 and 10 % (v\v) FBS containing DFO every 3 days. At the indicated times, cells were harvested by trypsinization and counted with a haemocytometer after staining with 0.4 % (w\v) Trypan Blue (Gibco BRL) to exclude dead cells.
Proliferation rate by 5-bromo-2h-deoxyuridine (BrdU) incorporation assay
The proliferation rate was analysed by counting the number of cells incorporating BrdU and comparing with the total number of cells stained with 4,6-diamidino-2-phenylindole (DAPI), according to the manufacturer's instructions (BrdU incorporation assay kit ; Boehringer Mannheim, Mannheim, Germany), with a slight modification. Subconfluent cells were seeded on to coverslips and treated in the absence or presence of DFO (500 µM) for the indicated periods. Cells were then labelled with 20 µM BrdU in DMEM\F12 containing 10 % (v\v) FBS for 4 h to increase BrdU incorporation. The cells were fixed with 70 % (v\v) ethanol in 50 mM glycine buffer (pH 2.0) for 20 min. The labelled cells were visualized by incubating with an anti-(BrdU) antibody and Cy3-conjugated anti-(mouse IgG) antibody. Co-staining with DAPI was applied to visualize total cells.
Cell-cycle analysis
Cell-cycle analysis was performed by propidium iodide (PI) staining according to the protocol provided with CycleTEST TM PLUS DNA reagent kit (Becton Dickinson, Mississauga, ON, Canada). Subconfluent cells treated in the absence or presence of DFO for the indicated periods were trypsinized, collected by centrifugation, and washed with, and resuspended in, PBS before fixing in 70 % (v\v) ethanol at a density of 1i10' cells\ml. After RNase digestion (0.1 mg of RNase A and 2 units\ml of RNase T1 at 37 mC for 1 h) and washing with PBS, the fixed cells were stained with 50 µg\ml PI for at least 30 min before analysis by flow cytometry (FACsorter ; Becton Dickinson). The instrument was set to collect 2i10% cells and the cell-cycle profile was analysed using CellQuest software.
Senescence-associated β-galactosidase (SA-β-gal) assay
SA-β-gal was assayed at pH 6.0 as described by Dimri et al. [27] with a slight modification. Briefly, cells were washed twice with PBS, fixed to plates by 3 % formaldehyde for 5 min, washed with PBS, and then incubated overnight in freshly prepared staining solution [40 mM citrate\phosphate buffer (pH 6.0) containing 1 mg\ml 5-bromo-4-chloroindol-3-yl β--galactopyranoside (' X-Gal ' ; Sigma, St. Louis, MO, U.S.A.), 5 mM potassium ferrocyanide, 5 mM potassium ferricyanide, 150 mM NaCl and 2 mM MgCl # ]. The stain was visible 12 h after incubation at 37 mC. The degree of senescence-associated cells was obtained by counting the number of blue-stained cells per field (0.5 cmi0.5 cm) and expressing as a percentage of the total number of cells. 
Neutralization of the TGF-β1 with an anti-(TGF-β1) antibody
Western-blot analysis and antibodies
Reverse transcriptase (RT)-PCR
Total RNA was prepared by using the guanidium method [28] , and cDNA was obtained by incubating 0.5 µg of total RNA with 50 pmol of oligo(dT) primer and 0.25 unit of AMV (' Avian Myeloblastosis Virus ') RT XL in a 20 µl reaction mixture (RNA PCR kit version 2.1 ; TaKaRa, Shiga, Japan) at 30 mC for 10 min, 56 mC for 30 min, and then 90 mC. A portion (100 ng) of the TGF-β1 primers (5h-GCCCTGGACACCAACTATT-3h and 5h-TCAGCTGCACTTGCAGGAG-3h, with the PCR product spanning from exons 5-7) and 50 ng of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) primers (5h-CCATGGA-GAAGGCTGGGG-3h and 5h-CAAAGTTGTCATGGATGA-CC-3h) were added to give a final volume of 100 µl in a single reaction mixture with 1 unit of Ex Taq polymerase (TaKaRa). PCR conditions were : denaturation at 94 mC for 30 s, annealing at 50 mC for 30 s, and elongation at 72 mC for 30 s. Serial PCR products from 25-32 cycles were screened. The final RT-PCR products were electrophoresed on 1.2 % (w\v) agarose gels, stained with 0.5 µg\ml of ethidium bromide solution, and visualized on a UV transilluminator.
RESULTS
DFO arrests the growth of Chang cells at G 1 phase in a dose-dependent manner
Exponentially growing asynchronous Chang cells, immortalized normal human hepatocytes, were treated with various concentrations of DFO, a water-soluble iron chelator, and the growth Figure 1A) show that there was a significant decline in growth rates of the DFO-treated cells in a dose-dependent manner. With DFO concentrations higher than 100 µM, almost complete growth arrest was evident after 48 h. No significant number of dead cells was observed until 4 days of DFO treatment, as judged by floating cells during culture or Trypan Blue-stained cells (results not shown). A number of dead cells appeared after 4 days of treatment with DFO concentrations higher than 100 µM, resulting in a slight decline of the growth curve. Next, using the BrdU incorporation assay, we examined further whether the growth arrest was caused by the inhibition of proliferation rate. As shown in Figure 1(B) , the percentage of BrdU-incorporated cells was clearly decreased from 60.3p5.9 % (control ; meanpS.D.) to 7.2p1.7 % (meanpS.D.) after 2 days of exposure to DFO, and few weakly labelled cells (0-2 %) were observed after the third day. It was therefore obvious that the initial growth arrest by DFO was due to a decreased proliferation rate.
In contrast with the low concentrations required for effective growth arrest in neuroblastoma, where 1-10 µM decreased the cell number by 50 % with massive apoptotic cell death after 24 h of exposure [24] , relatively higher concentrations (higher than 2 mM) were needed to induce apoptotic death in Chang cells. This difference could be due to the fact that liver is an ironstorage organ with much higher tolerance towards iron depletion than other organs, or that hepatocytes may have another hitherto unknown protective mechanism against iron depletion.
To analyse further the effect of DFO on the cell cycle, flow cytometric analyses with PI staining were performed. As shown in Figure 1(C) , cells in G " phase increased from 63 % (control) to 78 % (1 mM) and 82 % (2 mM) after 3 days of exposure with DFO. The number of cells arrested at the G " phase also increased in a time-dependent manner, with 83 % after 7 days of exposure to 1 mM DFO ( Figure 1D) . Our data therefore demonstrate that the growth inhibition of Chang cells by DFO was caused primarily by arrest at the G " phase of the cell cycle in a dose-and time-dependent manner. Senescence-like growth arrest by iron chelation in hepatocytes
Irreversible senescence-like change of Chang cells by DFO
During the growth arrest by DFO, we observed that Chang cells progressively displayed enlarged morphology mimicking replicative-senescent cells. It is generally accepted that replicativesenescent cells display flat cell morphology, are irreversibly arrested during the G " phase of cell cycle, have increased expression of p16 INK%a , p21 Cip" and p19 ARF (where ARF is alternative reading frame), enhanced p53 activity and reduced PARP expression [14] [15] [16] [17] [18] 29] . To confirm whether DFO induced cellular senescence in Chang cells, first we examined microscopic morphological changes. Chang cells started to manifest enlarged and flattened cell morphology within 24 h after treatment with 1 mM DFO and their size progressively increased until 7 days of treatment (Figure 2A ). Another widely used marker for cellular senescence is the acquisition of SA-β-gal activity [27] , and DFO-treated Chang cells clearly induced SA-β-gal activity ( Figures 2B and  2C) . The proportion of SA-β-gal-stained cells increased as the exposure time increased, with 14.3 % of the total cells after exposure for 3 days with 1 mM DFO, 33.7 % after 5 days, and 59.3 % after 7 days of treatment ( Figures 2B and 2C) . Dosedependent SA-β-gal activation was also observed (results not shown). We therefore decided to use 1 mM DFO to analyse the molecular mechanism involved, because of its intermediate, but evident, effect on both growth arrest and acquisition of the senescent phenotype.
To explore the irreversibility of the senescence-like property, Chang cells were treated with 1 mM DFO for various periods of time prior to the culture medium being replaced with medium lacking DFO. Transient exposure of the cells to DFO for at least 1 day induced a small proportion of the cells to exhibit SA-β-gal activity, and the proportion of SA-β-gal-stained cells increased as the exposure time was increased ( Figure 2D) . Moreover, the number of stained cells was higher in cells that were exposed to DFO for 3 days followed by normal media for 3 days (Figure 2D , bar 4) than those exposed to DFO for 3 days only ( Figure 2C, bar 2 ). This result suggested that, once stimulated by DFO, the cells kept progressing to senescence even in the absence of DFO, and that the senescence-like characteristic induced by DFO was irreversible. To confirm further the senescent characteristic induced by DFO, expression of PARP was monitored by Western-blot analysis. PARP has been shown to limit the extent of DNA damage-induced genomic instability and to decrease in expression during cellular senescence, thus possessing a role as a senescent marker [29] [30] [31] . As shown in Figure 2 (E), PARP expression in Chang cells started to decrease after 3 days of exposure to DFO without any appearance of the 89 kDa fragmented PARP, as detected by an anti-(PARP) antibody that detects both the full-length and fragmented PARP. To prove further that the decrease in PARP was not caused by cleavage by activated caspase-3, the expression level of caspase-3 was also analysed. No decrease in the level of procaspase-3 expression was observed, indicating that caspase-3 was not activated. These results imply that genomic stability might have been decreased during the DFO-induced genotoxic stress condition. Taken together, it can be summarized at this point that the G " arrest induced by DFO is accompanied by a dose-dependent senescencelike change in the cells.
Growth arrest by DFO associated with induction of p27, but not of p21
Several reports [14] [15] [16] [17] [18] 32, 33] have indicated that cellular senescence is induced by the overexpression of p16 INK%A , p21 Cip" or p53, implying their roles as major mediators in the senescent process. To test this possibility, the expression of p53 was 
Figure 4 Differential phosphorylation level on various phosphorylation sites of p53
Time-dependent phosphorylation of p53 on Ser-15, Ser-20 and Ser-392 was examined by Western-blot analysis using specific antibodies against each phosphorylated residue of p53. X-34A, adriamycin-treated X-34 cell lysate was used as positive control for detection of Ser-20 phosphorylation. Representative blots from three independent experiments are shown.
examined by Western-blot analysis. As shown in Figure 3 , p53 protein expression increased progressively until day 3 of DFO treatment, and then slowly returned back to control levels. However, p21 Cip" , a downstream target protein of p53, was not Kip1 was analysed by Western blotting. The levels of α-actin were used as a protein-loading control. Molecular-mass markers (in kDa) are indicated on the left. Representative blots from three independent experiments are shown.
Figure 6 Senescence-like growth arrest by iron chelation independent of p53
Hep3B and Huh7 cells were treated in the absence (C) or presence (D3) of DFO for 3 days. (A) Cells were stained to assess SA-β-gal activity. To intensify the staining with 5-bromo-4-chloroindol-3-yl β-D-galactopyranoside, the incubation time was increased to 48 h (D3a). Lane SM shows a 100 bp ladder. Magnification, i65. (B) Protein expression of p53 and p27 Kip1 following treatment was determined by Western blotting. (C) mRNA levels of TGF-α1 and GAPDH in Hep3B and Huh7 cells was determined by RT-PCR. The lanes correspond to those shown in (B). A 100 bp ladder is shown on the right. Representative blots from three independent experiments are shown.
induced, indicating that the increased level of p53 protein did not play a role as the transcriptional activator of p21 Cip" expression. This result encouraged us to screen the regulators involved in G " arrest, and the expression levels of CDKIs, including p16 INK%A , p15 INK%B and p27 Kip" , were analysed by immunoblotting. Neither p16 INK%A nor p15 INK%B were accumulated, whereas the level of p16 INK%A and p21 Cip" decreased. However, there was an obvious induction of p27 Kip" after exposure for 3 days, and its induction continued to increase thereafter. These findings suggested that the induction of p27 Kip" might play a role as a mediator of this cell-cycle arrest.
Next, we asked why the increased p53 did not induce p21 Cip" . Recent studies [34] [35] [36] have shown that differential phosphorylation on various sites of p53 can modulate its stability as well as induction of its downstream gene products. Therefore we examined the level of phosphorylation of each phosphorylation site of p53 by using antibodies which specifically recognize a particular phosphorylated residue of the p53 protein. As shown in Figure 4 , phosphorylation of Ser-15 increased proportionately with the increase in p53 expression, whereas no phosphorylation of Ser-20 was detected. A slight transient increase in phosphorylation of Ser-392 was observed. These observations possibly indicate that markedly enhanced phosphorylation of Ser-15, but with no phosphorylation of Ser-20, blocked the p21 Cip" induction by p53, findings consistent with a previous report [35] . Senescence-like growth arrest by iron chelation in hepatocytes
Induction of p27 expression mediated by transcriptional induction of TGF-β1
So far, the results described above suggested that the upregulation of p27 Kip" expression was associated in DFO-induced senescence-like G " arrest in Chang cells. We therefore attempted to explore possible factors in the induction of p27 Kip" expression. Since several previous reports [37, 38] have described that p27 Kip" expression can be induced by TGF-β1, we determined the mRNA level of TGF-β1 by using RT-PCR. As seen in Figure 5(A) , TGF-β1 mRNA was induced after 3 days of DFO stimulation, which correlated well with p27 Kip" expression. To confirm further whether TGF-β1 was truly responsible for inducing p27 Kip" expression, p27 Kip" levels were examined after neutralization with anti-(TGF-β1) antibodies. Thus Chang cells were stressed with 1 mM DFO either in the presence of 2 µg\ml anti-(TGF-β1) antibodies or the antibodies were added 1 day after DFO treatment. In both cases, induction of p27 Kip" was completely abolished by neutralization with anti-(TGF-β1) antibodies ( Figure 5B ), proving that induction of p27 Kip" by iron chelation was mediated by TGF-β1.
Senescence-like growth arrest by iron chelation is independent of p53
The results in Figure 3 indicated that p53 induction was most likely unrelated to the DFO-induced senescence-like growth arrest. To verify further the involvement of p53, we added DFO to the human hepatoma cell lines Huh7, which have mutant p53, and Hep3B, which lack p53. In both cell lines, DFO induced SA-β-gal activity ( Figure 6A ), although the intensity was weaker than in Chang cells and it took longer for the staining to be visualized, suggesting that p53 expression is not required in the DFO-induced senescence-like change. However, both p27 Kip" and TGF-β1 were not induced in Hep3B cells ( Figures 6B and  6C ), implying that another hitherto unknown mechanism might be involved in DFO-induced senescence-like growth arrest in hepatocytes.
DISCUSSION
It is well established that iron is essential in the maintenance of cellular life, and iron overload is often found associated with cancerous cells. For the above reasons, iron deprivation has often been employed to inhibit the proliferation of malignant cells. The addition of DFO has been shown to induce growth arrest at G " phase in various cell lines [24, 39, 40] , and a number of mechanisms, such as blockage of N-myc expression [23] , decrease in nuclear expression of p34 cdc# [39] or inhibition of cyclin A protein expression [40] , have been postulated. Growth arrest at G # \M phase in certain cells, including glioma cells [41] and K562 leukaemia cells [42] , has also been observed, which is dependent on dose and duration of DFO treatment. In the present study, we have demonstrated that prolonged treatment of Chang cells with a subcytotoxic concentration of DFO induced senescence-like G " arrest, as evidenced by reduction of growth rate, G " accumulation of the cells, emergence of biomarkers for replicative senescence, such as a typical flattened and enlarged morphology, SA-β-gal activity and decrease of PARP expression, and finally their irreversibility (Figure 1 and 2) . To the best of our knowledge, these findings are the first to report a growtharrest model representing replicative senescence induced by iron chelation.
On the basis of the immunoblot analysis of negative cell-cycle regulators, G " arrest by DFO was most likely associated with the induction of p27 Kip" and not the involvement of three other CDKIs, p21 Cip" , p16 INK%A and p15 INK%B (Figure 3 ). p27 Kip" is a potent inhibitor of cyclin D\CDK4 and cyclin E\CDK2 activities, which govern cell-cycle progression at restriction and late transition points of G " respectively. p27 Kip" has been shown to be generally expressed at a high level in quiescent cells, present in a sequestered state in proliferating cells at a lower level, and rapidly down-regulated upon growth-factor stimulation [14] [15] [16] . When triggered by TGF-β1 or contact inhibition, the role of p27 Kip" as a major player in G " arrest has been well accepted [37, 38] . However, p27 Kip" induction by iron chelation has never been reported before, despite many studies on G " arrest by DFO. Our observations strongly suggested that gain of p27 Kip" expression by DFO could play a certain role in maintaining the growth arrest of hepatocytes at G " phase by DFO with acquisition of senescence-like phenotype. This suggestion is in agreement with a recent report [19] showing that senescence-like growth arrest by the phosphoinositide 3-kinase inhibitor LY294002 was mediated by p27 Kip" , whereas p16 INK%A , p21 Cip" , p19 ARF and p53 were down-regulated.
As evidenced by RT-PCR for TGF-β1 mRNA and by neutralization with antibodies against TGF-β1 ( Figure 5 ), TGF-β1 induction is heavily involved in the induction of p27 Kip" . Neutralization of TGF-β1 for 2 days with antibodies was sufficient to block p27 Kip" induction. This indicated that the TGF-β1 induced by DFO was released from the cells and stimulated the cells again in an autocrine manner as the major inducer of p27 Kip" expression. Recent reports [43, 44] that TGF-β1 can induce premature senescence in human diploid fibroblasts support further the role of TGF-β1 as a possible mediator in DFO-induced senescencelike arrest. Unfortunately, G " -arrested cells or senescent phenotype, such as cells having SA-β-gal activity, could not be reversed after neutralization with 3 µg\ml anti-(TGF-β1) antibody for 3 days as analysed by FACS and microscopic observation (results not shown). These results indicate that blocking of TGF-β1\p27 Kip" signalling is not sufficient to reverse the G " arrest and gain of SA-β-gal activity, suggesting that other mechanisms might be involved in the arrest. The existence of another possible signalling pathway was also suggested by the observation with DFO-treated Hep3B hepatoma cells, where no TGF-β1 and p27 Kip" were induced despite acquisition of the senescent phenotype ( Figure 6 ). One possible explanation for the reason of why blocking the TGF-β1\p27 Kip" induction could not reverse the arrest is that iron chelation by DFO inhibited RR, which is required for DNA synthesis, resulting in blockage of the cell-cycle progression from G " to S-phase [42] . There is no doubt that the RR activity cannot be recovered by the neutralization of TGF-β1. This explanation can be supported further by recent reports [45, 46] that inhibition of RR by hydroxyurea induced senescence-like growth arrest in human diploid fibroblasts and erythroleukaemia cells. In addition, we observed that DFO induced early irreversible mitochondrial dysfunction, implying that it might be involved in DFO-induced senescence-like G " arrest (Y.-S. Yoon, H. Cho, J.-H. Lee, K.-T. Lee and G. Yoon, unpublished work). However, in order to define more clearly the mechanism involved in DFO-induced senescence-like growth arrest of hepatocytes, possible involvement of other mediators should be pursued further. In addition the contribution of the induction of TGF-β1\p27 Kip" signalling in our system has yet to be studied.
Another unexpected observation was that p21 Cip" was not induced, whereas p53 was. It is well known that p53 acts as a general mediator and p21, the downstream target of p53, also plays an important role in replicative senescence [16] [17] [18] . Therefore it was of interest to observe that the DFO-induced p53 was non-functional in terms of p21 Cip" induction, although senescence-like arrest was induced by DFO. The reason for the inability of enhanced p53 to induce p21 Cip" could be explained by differential phosphorylation of p53 (Figure 4) , a finding in agreement with a previous report [35] demonstrating that increased phosphorylation on Ser-15 by DFO, but not on Ser-20, prevented p53 from inducing p21 Cip" expression in human MRC5 fibroblasts. p53-independent replicative senescence has been demonstrated in a few studies using cells lacking p53 [32, 33] . We also examined the effect of DFO on two different p53-negative cell lines, Huh7, human hepatoma cells harbouring mutant p53, and Hep3B cells, lacking p53. In both cell lines, DFO induced SA-β-gal activity ( Figure 6A) , suggesting that the DFO-induced senescence-like change did not require p53 expression.
In conclusion, iron chelation by DFO can inhibit cellular proliferation, especially of hepatocyte cell lines, which is accompanied by senescence-like characteristics, thus expanding our understanding on the mechanisms involved in the growth inhibition of hepatocytes by iron depletion.
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